Genital Diseases, Female  >>  gemcitabine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gemcitabine / Generic mfg.
NCT00191100: Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix

Completed
3
515
RoW
Gemcitabine, LY188011, Gemzar, Cisplatin, Brachytherapy, Pelvic radiation
Eli Lilly and Company
Cancer of Cervix
04/08
04/08
NCT00191646: An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy

Completed
3
919
US
Gemcitabine, LY188011, Gemzar, Paclitaxel, Carboplatin
Eli Lilly and Company
Genital Neoplasms, Female, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pelvic Neoplasms, Peritoneal Neoplasms
08/09
08/09
OCEANS, NCT00434642: A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma

Checkmark SGO 2014
Mar 2014 - Mar 2014: SGO 2014
Checkmark P3 data-ESMO
Sep 2012 - Sep 2012: P3 data-ESMO
Checkmark P3 data (Ovarian)-OCEANS
More
Completed
3
484
NA
Carboplatin, Gemcitabine, Bevacizumab, Avastin, Placebo
Genentech, Inc.
Ovarian Cancer
09/10
07/13
PENELOPE, NCT01684878 / 2011-005975-17: Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer

Checkmark Platinum-Resistant Ovarian Cancer
Jun 2016 - Jun 2016: Platinum-Resistant Ovarian Cancer
Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Checkmark P2 data
More
Completed
3
208
Europe
Gemcitabine (Chemotherapy), Paclitaxel (Chemotherapy), Pertuzumab, Placebo, Topotecan (Chemotherapy)
Hoffmann-La Roche
Ovarian Cancer
01/15
04/16

Download Options